神经生物标志物市场战略、顶尖企业、增长机会、2031 年分析及预测

  • Report Code : TIPRE00003515
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

神经生物标志物市场规模预计在 2021 年为 54.009 亿美元,在 2023 年为 XX 百万美元,预计到 2031 年将达到 186.0093 亿美元;预计 2031 年的复合年增长率为 13.6%。市场受到神经系统疾病患病率上升和对神经生物标志物研究日益关注等因素的推动。然而,与生物标志物相关的担忧可能会在预测期内阻碍市场增长。此外,整个医疗保健行业的快速发展可能仍是神经生物标志物市场的主要趋势。 

 

神经生物标志物市场分析

神经系统疾病在疾病诊断、治疗和管理方面给卫生系统带来了沉重的负担。一些主要的神经系统疾病包括癫痫、阿尔茨海默病、多发性硬化症、脊髓性肌萎缩症 (SMA)、杜氏肌营养不良症等。老年人群易患神经系统疾病。神经病、帕金森病、阿尔茨海默病和肌张力障碍是影响老年人的最常见的神经系统疾病。根据美国国立卫生研究院 (NIH) 的数据,世界人口的 8.5%(即约 6.17 亿人)年龄在 65 岁以上。根据世界卫生组织 (WHO) 的数据,神经系统疾病占全球疾病负担的 6.3%,是全球主要死亡原因之一。此外,发达国家 13.2% 的死亡和中低收入国家的 16.8% 的死亡是由于神经系统疾病造成的。发达经济体和新兴经济体中神经系统疾病病例的增加正在推动神经系统生物标志物市场的增长。   

 

神经生物标志物市场概览

生物标记物是指示疾病存在的分子。神经系统疾病的生物标记物在早期并不常见;然而,随着技术的进步,我们可以通过测量生物标记物来追踪大脑的健康状况。这有助于更早地发现疾病,诊断方法创伤性更小,可以加快药物开发速度,并有望成为一种有效的治疗方法。 

全球神经生物标志物市场按地区细分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。在北美,美国是最大的神经生物标志物市场。美国神经生物标志物市场的增长归功于市场参与者采用有机和无机战略进行市场开发。例如,2020 年 5 月,Quanterix Corporation 宣布将扩大其强大的即用型 Simoa 试剂盒菜单,包括苏氨酸 181 磷酸化的 tau (p-tau181),这是一种用于研究阿尔茨海默病病理学的高度特异性 生物标志物 ,存在于脑脊液 (CSF)、血清和血浆中。根据阿尔茨海默病协会的数据,到 2020 年,估计有 580 万 65 岁或以上的美国人患有阿尔茨海默病,预计到 2050 年这一数字将达到 1,380 万。因此,在预测期内,神经系统疾病的患病率不断上升可能会有利于市场的增长。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

神经生物标志物市场:

神经生物标志物市场
  • Neurological Biomarkers Market
    复合年增长率(2023 - 2031)
    13.6%
  • 2021 年市场规模
    54.009 亿美元
  • 市场规模 2031
    18600.93 百万美元

市场动态

增长动力
  •  
  • 神经系统疾病发病率上升
  • 医疗保健快速发展
未来趋势
  •  
  • 生物标志物发现的进展
  • 更加注重个性化医疗
机会
  •  
  • 新型生物标志物的开发
  • 药物开发与生物标志物的整合
  • 注重早期发现和预防

关键人物

  • 赛默飞世尔科技公司
  • 雅培
  • Myriad Genetics 公司
  • Bio Rad 实验室公司
  • Qigen
  • Banyan Biomarkers 公司
  • Immunarray私人有限公司
  • Quest Diagnostics 公司
  • 珀金埃尔默公司
  • 默克密理博

区域概况

Neurological Biomarkers Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Neurological Biomarkers Market产品
  • 蛋白质组学生物标志物
  • 基因组学生物标志物
  • 代谢组学生物标志物
  • 成像生物标志物
Neurological Biomarkers Market应用
  • 阿尔茨海默病
  • 帕金森病
  • 精神分裂症
  • 亨廷顿氏病
  • 脊髓性肌萎缩症
Neurological Biomarkers Market最终用户
  • 制药和生物技术公司
  • 临床诊断
  • 研究机构
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

神经生物标志物市场驱动因素和机遇

 

医疗保健快速发展,利好整体市场

医疗保健和药物研发领域的快速发展正在推动神经系统疾病治疗新疗法的推出世界卫生组织、美国国家神经疾病和中风研究所和美国国立卫生研究院等机构正在采取建设性措施鼓励研究活动并寻找治疗神经系统疾病的方法。美国国家神经疾病和中风研究所 (NINDS) 生物标志物计划专注于提高神经治疗临床研究的质量和效率,并支持生物标志物验证。该计划通过为研究活动提供资金来促进严格的生物标志物识别和验证。神经退行性疾病生物标志物 (BAND) 是一个旨在促进对阿尔茨海默病 (AD)、帕金森病 (PD) 和其他神经退行性疾病的研究分析的计划。阿尔茨海默病协会、英国阿尔茨海默病研究协会 (ARUK)、迈克尔·J·福克斯帕金森病研究基金会 (MJFF) 和韦斯顿脑研究所 (Weston) 在该计划下资助了多个奖项。

在预测期内,这一需求可能会推动全球神经生物标志物市场的发展。    

 

生物标志物发现的进展——神经生物标志物市场的机遇

近年来,生物标志物的发现不断增加。例如,2021 年 4 月,一组 NIH 资助的机构使用 Advanced Brain Monitoring, Inc. 的 Sleep Profiler EEG 睡眠监测器发现了两种与神经退行性疾病(帕金森病和痴呆症)相关的新型睡眠生物标志物。这一发现不仅对神经系统疾病至关重要,而且生物标志物有助于理解与大脑相关的事物。近期的这些进展可能会为神经生物标志物市场带来诱人的增长机会。  

 

神经生物标志物市场报告细分分析

有助于得出神经生物标志物市场分析的关键部分是产品和应用。

  • 根据产品,生物标志物可细分为蛋白质组生物标志物、基因组生物标志物、代谢组生物标志物、成像生物标志物等。2023 年, 基因 组生物标志物细分市场占据神经生物标志物市场的最大份额,预计同一细分市场在预测期内将以最快的速度增长。基因组学在基于个体遗传变异的个性化诊断和治疗方面取得了重大进展。基因组生物标志物已被证明可用于识别帕金森病、阿尔茨海默病、亨廷顿病、自闭症等神经系统疾病。个性化药物和用于神经系统疾病诊断和治疗应用的基因分析的兴起预计将在未来几年促进该细分市场的增长。
  • 应用领域细分为阿尔茨海默病、帕金森病、精神分裂症、亨廷顿病、脊髓性肌萎缩症等。阿尔茨海默病领域在 2023 年占据了神经生物标志物市场的最高份额,预计同一领域将在 2024 年至 2031 年间以显着的速度增长。阿尔茨海默病是一种渐进性疾病,导致脑细胞萎缩(退化)并最终死亡。随着疾病的发展,患者会出现严重的记忆障碍,无法执行日常任务。目前可用的药物可能会暂时改善症状或减缓衰退速度。预计该疾病发病率的增加将在未来几年内导致神经生物标志物市场的增长。
  • 根据最终用户,市场分为制药和生物技术公司、临床诊断和研究组织。2023 年,制药和生物技术公司占据了最大的市场份额,预计未来几年该细分市场也将以最快的速度增长。因此,上述因素是神经生物标志物市场规模增长的原因。

 

神经生物标志物市场份额(按地区)分析

神经生物标志物市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美/南美和中美洲。

亚太地区预计将成为所有其他地区中增长最快的地区。由于对优质诊断和治疗解决方案的需求不断增加、神经系统疾病患病率不断上升以及对研发活动的日益重视等因素,预计亚太地区市场的增长速度将更快。此外,在预测期内,医疗保健基础设施的发展和增加投资以促进研究活动预计将推动亚太地区神经生物标志物市场的发展。

 

神经生物标志物市场报告范围

报告属性细节
2021 年市场规模54.009亿美元
2031 年市场规模18600.93 百万美元
全球复合年增长率(2023 - 2031)13.6%
史料2021-2022
预测期2024-2031
涵盖的领域按产品
  • 蛋白质组学生物标志物
  • 基因组学生物标志物
  • 代谢组学生物标志物
  • 成像生物标志物
按应用
  • 阿尔茨海默病
  • 帕金森病
  • 精神分裂症
  • 亨廷顿氏病
  • 脊髓性肌萎缩症
按最终用户
  • 制药和生物技术公司
  • 临床诊断
  • 研究机构
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 赛默飞世尔科技公司
  • 雅培
  • Myriad Genetics 公司
  • Bio Rad 实验室公司
  • Qigen
  • Banyan Biomarkers 公司
  • Immunarray私人有限公司
  • Quest Diagnostics 公司
  • 珀金埃尔默公司
  • 默克密理博
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

神经生物标志物市场新闻和最新发展

通过收集主要和次要研究后的定性和定量数据来评估神经生物标志物市场,其中包括重要的公司出版物、协会数据和数据库。以下是神经生物标志物和策略市场发展的列表:

  • 2021 年 4 月,Quantrix Corp. 宣布与行业领先专家举行网络研讨会,讨论与 pTau181、pTau217、pTau231 和其他神经系统生物标志物的超灵敏量化相关的神经系统进展(来源:Quantrix Corp,新闻稿,2021 年)   

 

神经生物标志物市场报告覆盖范围和交付成果

“神经生物标志物市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.